280 related articles for article (PubMed ID: 26595551)
1. Immunogenicity of Influenza Vaccine for Patients with Inflammatory Bowel Disease on Maintenance Infliximab Therapy: A Randomized Trial.
deBruyn J; Fonseca K; Ghosh S; Panaccione R; Gasia MF; Ueno A; Kaplan GG; Seow CH; Wrobel I
Inflamm Bowel Dis; 2016 Mar; 22(3):638-47. PubMed ID: 26595551
[TBL] [Abstract][Full Text] [Related]
2. Immunogenicity and safety of influenza vaccination in children with inflammatory bowel disease.
deBruyn JC; Hilsden R; Fonseca K; Russell ML; Kaplan GG; Vanderkooi O; Wrobel I
Inflamm Bowel Dis; 2012 Jan; 18(1):25-33. PubMed ID: 21472826
[TBL] [Abstract][Full Text] [Related]
3. Immune response to influenza vaccine in children with inflammatory bowel disease.
Lu Y; Jacobson DL; Ashworth LA; Grand RJ; Meyer AL; McNeal MM; Gregas MC; Burchett SK; Bousvaros A
Am J Gastroenterol; 2009 Feb; 104(2):444-53. PubMed ID: 19174786
[TBL] [Abstract][Full Text] [Related]
4. Immune response to influenza vaccine in pediatric patients with inflammatory bowel disease.
Mamula P; Markowitz JE; Piccoli DA; Klimov A; Cohen L; Baldassano RN
Clin Gastroenterol Hepatol; 2007 Jul; 5(7):851-6. PubMed ID: 17544875
[TBL] [Abstract][Full Text] [Related]
5. Immunogenicity of Quadrivalent Influenza Vaccine for Patients with Inflammatory Bowel Disease Undergoing Immunosuppressive Therapy.
Shirai S; Hara M; Sakata Y; Tsuruoka N; Yamamoto K; Shimoda R; Gomi Y; Yoshii H; Fujimoto K; Iwakiri R
Inflamm Bowel Dis; 2018 Apr; 24(5):1082-1091. PubMed ID: 29538682
[TBL] [Abstract][Full Text] [Related]
6. Infliximab and/or immunomodulators inhibit immune responses to trivalent influenza vaccination in adults with inflammatory bowel disease.
Hagihara Y; Ohfuji S; Watanabe K; Yamagami H; Fukushima W; Maeda K; Kamata N; Sogawa M; Shiba M; Tanigawa T; Tominaga K; Watanabe T; Fujiwara Y; Hirota Y; Arakawa T
J Crohns Colitis; 2014 Mar; 8(3):223-33. PubMed ID: 24011513
[TBL] [Abstract][Full Text] [Related]
7. Immunogenicity and Safety of Influenza Vaccine in Inflammatory Bowel Disease Patients Treated or not with Immunomodulators and/or Biologics: A Two-year Prospective Study.
Launay O; Abitbol V; Krivine A; Slama LB; Bourreille A; Dupas JL; Hébuterne X; Savoye G; Deplanque D; Bouhnik Y; Pelletier AL; Galtier F; Laharie D; Nachury M; Zerbib F; Allez M; Bommelaer G; Duclos B; Lucht F; Gougeon ML; Tartour E; Rozenberg F; Hanslik T; Beaugerie L; Carrat F;
J Crohns Colitis; 2015 Dec; 9(12):1096-107. PubMed ID: 26351392
[TBL] [Abstract][Full Text] [Related]
8. Antibody Responses to Influenza Vaccination are Diminished in Patients With Inflammatory Bowel Disease on Infliximab or Tofacitinib.
Liu Z; Alexander JL; Yee Eng K; Ibraheim H; Anandabaskaran S; Saifuddin A; Constable L; Castro Seoane R; Bewshea C; Nice R; D'Mello A; Jones GR; Balarajah S; Fiorentino F; Sebastian S; Irving PM; Hicks LC; Williams HRT; Kent AJ; Linger R; Parkes M; Kok K; Patel KV; Teare JP; Altmann DM; Boyton RJ; Hart AL; Lees CW; Goodhand JR; Kennedy NA; Pollock KM; Ahmad T; Powell N
J Crohns Colitis; 2024 Apr; 18(4):560-569. PubMed ID: 37941436
[TBL] [Abstract][Full Text] [Related]
9. Immunogenicity of High Dose Influenza Vaccine for Patients with Inflammatory Bowel Disease on Anti-TNF Monotherapy: A Randomized Clinical Trial.
Caldera F; Hillman L; Saha S; Wald A; Grimes I; Zhang Y; Sharpe AR; Reichelderfer M; Hayney MS
Inflamm Bowel Dis; 2020 Mar; 26(4):593-602. PubMed ID: 31504526
[TBL] [Abstract][Full Text] [Related]
10. Influenza vaccine immunogenicity in 6- to 23-month-old children: are identical antigens necessary for priming?
Walter EB; Neuzil KM; Zhu Y; Fairchok MP; Gagliano ME; Monto AS; Englund JA
Pediatrics; 2006 Sep; 118(3):e570-8. PubMed ID: 16950948
[TBL] [Abstract][Full Text] [Related]
11. Serological response to the 2009 H1N1 influenza vaccination in patients with inflammatory bowel disease.
Cullen G; Bader C; Korzenik JR; Sands BE
Gut; 2012 Mar; 61(3):385-91. PubMed ID: 21757451
[TBL] [Abstract][Full Text] [Related]
12. Immunogenicity and safety of an inactivated quadrivalent influenza vaccine in healthy adults: a phase II, open-label, uncontrolled trial in Japan.
Tsurudome Y; Kimachi K; Okada Y; Matsuura K; Ooyama Y; Ibaragi K; Kino Y; Ueda K
Microbiol Immunol; 2015 Oct; 59(10):597-604. PubMed ID: 26272602
[TBL] [Abstract][Full Text] [Related]
13. Vaccination against influenza in patients with systemic sclerosis.
Litinsky I; Balbir A; Zisman D; Mandelboim M; Mendelson E; Feld J; Braun Y; Anouk M; Kaufman I; Paran D; Caspi D; Elkayam O
Clin Exp Rheumatol; 2012; 30(2 Suppl 71):S7-11. PubMed ID: 22409886
[TBL] [Abstract][Full Text] [Related]
14. Immunogenicity and sustainability of the immune response in Brazilian HIV-1-infected individuals vaccinated with inactivated triple influenza vaccine.
Souza TM; Santini-Oliveira M; Martorelli A; Luz PM; Vasconcellos MT; Giacoia-Gripp CB; Morgado M; Nunes EP; Lemos AS; Ferreira AC; Moreira RI; Veloso VG; Siqueira M; Grinsztejn B; Camacho LA
J Med Virol; 2016 Mar; 88(3):426-36. PubMed ID: 26267817
[TBL] [Abstract][Full Text] [Related]
15. Immunogenicity, safety and reactogenicity of a mammalian cell-culture-derived influenza vaccine in healthy children and adolescents three to seventeen years of age.
Vesikari T; Block SL; Guerra F; Lattanzi M; Holmes S; Izu A; Gaitatzis N; Hilbert AK; Groth N
Pediatr Infect Dis J; 2012 May; 31(5):494-500. PubMed ID: 22301476
[TBL] [Abstract][Full Text] [Related]
16. [The efficiency of influenza vaccines in patients with inflammatory bowel disease on immunosuppressive therapy].
Farkas K; Terhes G; Deák J; Bálint A; Nagy F; Szepes Z; Wittmann T; Molnár T
Orv Hetil; 2012 Nov; 153(47):1870-4. PubMed ID: 23160078
[TBL] [Abstract][Full Text] [Related]
17. Booster influenza vaccination does not improve immune response in adult inflammatory bowel disease patients treated with immunosuppressives: a randomized controlled trial.
Matsumoto H; Ohfuji S; Watanabe K; Yamagami H; Fukushima W; Maeda K; Kamata N; Sogawa M; Shiba M; Tanigawa T; Tominaga K; Watanabe T; Fujiwara Y; Hirota Y; Arakawa T
J Gastroenterol; 2015 Aug; 50(8):876-86. PubMed ID: 25672513
[TBL] [Abstract][Full Text] [Related]
18. Benefits of increasing the dose of influenza vaccine in residents of long-term care facilities: a randomized placebo-controlled trial.
Cools HJ; Gussekloo J; Remmerswaal JE; Remarque EJ; Kroes AC
J Med Virol; 2009 May; 81(5):908-14. PubMed ID: 19319953
[TBL] [Abstract][Full Text] [Related]
19. The safety and immunogenicity of trivalent inactivated influenza vaccination: a study of maternal-cord blood pairs in Taiwan.
Lin SY; Wu ET; Lin CH; Shyu MK; Lee CN
PLoS One; 2013; 8(6):e62983. PubMed ID: 23762229
[TBL] [Abstract][Full Text] [Related]
20. Declining responsiveness to influenza vaccination with progression of human pregnancy.
Schlaudecker EP; Ambroggio L; McNeal MM; Finkelman FD; Way SS
Vaccine; 2018 Jul; 36(31):4734-4741. PubMed ID: 29941326
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
